DalsnaFinance

BMO raises Merck stock price target to $142 on Keytruda Qlex uptake

Stocks Investing.com Australia By Investing.com Australia 13 Jul 2026 13:27 1 min read
BMO raises Merck stock price target to $142 on Keytruda Qlex uptake

BMO raises Merck stock price target to $142 on Keytruda Qlex uptake  Investing.com Australia

BMO raises Merck stock price target to $142 on Keytruda Qlex uptake Investing.com Australia

Read the full story on Investing.com Australia → Opens the original article on news.google.com

Summary aggregated from Investing.com Australia's public RSS feed. The full reporting belongs to Investing.com Australia — please read it on their site.